India approves Serum-Oxford, Bharat Biotech COVID vaccines for emergency use
Veröffentlicht: 4. Januar 2021 | Autor: Oeconomicus | Abgelegt unter: AstraZeneca, Bharat Biotech International Limited, India, Drugs Controller General of India (DCGI), Ministry of Health & Family Welfare | Tags: Covaxin, emergency use authorisation | Hinterlasse einen KommentarIndia approves Serum-Oxford, Bharat Biotech COVID vaccines for emergency use
Two of the leading coronavirus vaccine contenders in India have been granted approval for restricted use.
Oxford-AstraZeneca’s coronavirus vaccine Covishield, manufactured by Serum Institute of India and Bharat Biotech’s COVID vaccine Covaxin have been approved for emergency use authorisation.
The Drug Controller General of India VG Somani said that the Central Drugs Standard Control Organisation (CDSCO) gave its approval followed by the recommendation of the Subject Expert Committee (SEC) that recommended both the vaccines for emergency use.
[…]
Source, english
Source, deutsch
Oeconomicus 